Home › Funds › BML Capital Management, LLC › IMA

BML Capital Management, LLC position in IMA

IMAGENEBIO INC · Health Care

BML Capital Management, LLC reported holding 200,730 shares of IMA (IMAGENEBIO INC) in its Q3 2026 13F filing — a position valued at US$919K, representing 0.49% of its reported portfolio and ranking #17 among its reported holdings. BML Capital Management, LLC has disclosed IMA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)200.73K sh
Reported value held$919.34K
Portfolio Weight0.49%
First reportedQ3 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BML Capital Management, LLC's IMA position evolved

BML Capital Management, LLC first disclosed a stake in IMA in Q3 2025 at 182,509 shares (US$1.5M). Across 5 filings, BML Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 200,730 shares valued at US$919K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 182.51K $1.49M New
Q4 2025 177.03K $1.22M Reduce
Q1 2026 200.73K $1.00M Add
Q2 2026 200.73K $1.18M Hold
Q3 2026 200.73K $919.34K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IMA and 13F data

IMA (IMAGENEBIO INC) is a Health Care company. 38 other funds we track also report a position in IMA — the largest reported positions include BVF INC/IL (US$6.5M), Blue Owl Capital Holdings LP (US$5.2M), Cable Car Capital, LP (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IMA

All IMA fund holders →

FAQ

How long has BML Capital Management, LLC held IMA?

BML Capital Management, LLC has disclosed IMA holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is BML Capital Management, LLC's current position in IMA?

As of Q3 2026, BML Capital Management, LLC holds 200.73K shares of IMA (IMAGENEBIO INC), valued at $919.34K, representing 0.49% of its reported portfolio and ranking #17.

Has BML Capital Management, LLC been buying or selling IMA?

In the latest 13F filing (Q3 2026), BML Capital Management, LLC held unchanged its position in IMA.

Which other funds hold IMA?

Other major institutional holders of IMA include BVF INC/IL, Blue Owl Capital Holdings LP, Cable Car Capital, LP, among 38 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.